- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00976859
Efficacy of Cognitive Restructuring and Imagery Modification to Reduce the Feeling of Being Contaminated After Childhood Sexual Abuse
May 15, 2012 updated by: Regina Steil, Goethe University
Efficacy of a Two-session Treatment of Cognitive Restructuring and Imagery Modification (CRIM) to Reduce the Feeling of Being Contaminated (FBC) in Adult Survivors of Childhood Sexual Abuse
The purpose of this study is to determine whether a short term programme with internet research on the frequency of skin exchange and guided imagery modification is effective in the treatment of the feeling of being contaminated in female victims of childhood sexual abuse (CSA).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In the first session the women who suffer from a feeling of being contaminated after childhood sexual abuse are interviewed with the Structured Clinical Interview for DSM-IV (SCID) to ensure the clinical diagnosis of posttraumatic stress disorder and exclude women who meet the exclusion criteria.
They get questionnaires and protocol sheets to fill out until the intervention session after a week.
Afterwards the women are randomly assigned to an intervention group or a waitlist control group.
During the intervention session the women in the intervention group research via internet how many times their skin cells in different regions of their body have exchanged since the sexual abuse to get the information that their skin has changed hundreds and hundreds of times and has nothing in common with their skin in childhood or adolescence.
This first part of the intervention is based on a component of the DBT-PTSD.
Afterwards the therapist guides an imagery modification.
The women imagine the feeling of being contaminated and then to peel off their former contaminated skin and the maturing of hundreds of new clean skin cells to process the rational information of the internet research emotionally.
At the end of the intervention session patients get a tape with the guided imagery instruction and commit to listen to the tape daily to exercise the guided imagery modification until the third session after a week.
In the last session the homework is discussed and information on posttraumatic stress disorder and psychotherapeutic treatments of posttraumatic stress disorder is offered.Women in the waitlist control group get the same treatment as the women in the intervention group after a period of five weeks.
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hessen
-
Frankfurt, Hessen, Germany, D-60054
- Department of Clinical Psychology and Psychotherapy of the Johann Wolfgang Goethe University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Sexual abuse in childhood or adolescence
- Feeling of being contaminated
- Clinical diagnosis of posttraumatic stress disorder concerning the trauma of sexual abuse in childhood or adolescence according to DSM-IV
- Informed consent
Exclusion Criteria:
- Currently in psychotherapy
- Life time clinical diagnosis of schizophrenia, schizoaffective disorder or bipolar disorder according to DSM-IV
- Body mass index < 16,5
- Endangerment of self or others
- Clinical diagnosis of alcohol or drug addiction according to DSM-IV
- Mental retardation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Waitlist control group
|
Patients in the wait list control group are treated after a waiting period of five weeks
|
|
Experimental: Imagery Modification
Via a internet research patients collect data on skin renewal which is discussed afterwards; in a guided imagery modification the patients imagines the process of skin renewal and the building of new skin cells
|
Research via internet concerning the frequency of skin exchange and disputation of the collected information; in the guided imagery modification the therapist instructs the patient to imagine the feeling of being contaminated and the process of peeling off their former contaminated skin and the maturing of hundreds of new clean skin cells
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Intensity of the feeling of being contaminated (0-100: "not at all" till "extremely")
Time Frame: pre treatment, post treatment, follow up
|
pre treatment, post treatment, follow up
|
|
Vividness of the feeling of being contaminated (0-100: "not at all" till "extremely")
Time Frame: pre treatment, post treatment, follow up
|
pre treatment, post treatment, follow up
|
|
Distress associated to the feeling of being contaminated (0-100: "not at all" till "extremely")
Time Frame: pre treatment, post treatment, follow up
|
pre treatment, post treatment, follow up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Posttraumatic Diagnostic Scale
Time Frame: pre treatment, post treatment, follow up
|
pre treatment, post treatment, follow up
|
|
Clinician-administered PTSD Scale
Time Frame: pre treatment, follow up
|
pre treatment, follow up
|
|
Rosenberg Self-esteem scale
Time Frame: pre treatment, post treatment, follow up
|
pre treatment, post treatment, follow up
|
|
Beck Depression Inventory (BDI-II)
Time Frame: pre treatment, post treatment, follow up
|
pre treatment, post treatment, follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Regina Steil, PhD, Department of Clinical Psychology and Psychotherapy of the Johann Wolfgang Goethe University of Frankfurt
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2010
Primary Completion (Actual)
October 1, 2011
Study Completion (Actual)
October 1, 2011
Study Registration Dates
First Submitted
September 14, 2009
First Submitted That Met QC Criteria
September 14, 2009
First Posted (Estimate)
September 15, 2009
Study Record Updates
Last Update Posted (Estimate)
May 16, 2012
Last Update Submitted That Met QC Criteria
May 15, 2012
Last Verified
May 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDIEBESCHMUTZTHEITI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.